Pediatric Dermatology

Pediatric Molluscum Contagiosum: Reflections on the Last Challenging Poxvirus Infection, Part 2

Molluscum contagiosum (MC) is a common dermatologic infection that usually affects school-aged children, sexually active young adults, and immunocompromised individuals. It is a benign and self-limiting disease, with most cases undergoing spontaneous resolution within 6 to 9 months. However, a more severe and prolonged course is associated with immunosuppression or atopic dermatitis. Treatment is recommended because of the high rate of associated symptoms, risk for transmissibility, and cosmetic or social concerns. Therapeutic modalities are subdivided into 3 types: destructive, immunomodulatory, and antiviral. We review the advantages and disadvantages of various agents and discuss combination therapy.


 

Recommended Reading

Compliance May Be Biggest Treatment Barrier in Atopy
MDedge Dermatology
Blog: Highlight Evidence When Explaining Atopy to Parents
MDedge Dermatology
EADV: Exploring the Hapten Hypothesis of Atopic Disease
MDedge Dermatology
Sunscreens Don't Always Live Up to Advertising Promises
MDedge Dermatology
Aprepitant Relieves Refractory Chronic Pruritus
MDedge Dermatology
When to Consider Allergic Contact Dermatitis in an Atopic Child
MDedge Dermatology
Contact Irritants Can Incite Atopic Dermatitis in Children
MDedge Dermatology
FDA Recall: Tylenol Cold Products and Children's Benadryl, Motrin
MDedge Dermatology
Improvement in Treatment Adherence With a 3-Day Course of Fluocinonide Cream 0.1% for Atopic Dermatitis
MDedge Dermatology
Pediatric Molluscum Contagiosum: Reflections on the Last Challenging Poxvirus Infection, Part 1
MDedge Dermatology